Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Exactech, Inc.

United States·US-MF-000017730

Last updated September 17, 2026

Information

Country
United States
Address
2320, NW 66th Court, Gainesville, United States
LinkedIn
—
Facebook
—
Phone
(352) 377-1140
PRRC Contact
Christine Thomas
EUDAMED SRN
US-MF-000017730
FDA FEI Number
1038671
DUNS Number
157565946

Catalogue (10455)

Page 12 of 210
DeviceModel / ReferenceRegistriesClassStatus
Truliant 02-029-25-3730
FDA UDI
Class IActive
Optetrak Logic 02-019-30-0122
FDA UDI
Class IIUnknown
Alteon 01-030-48-0740
FDA UDI
Class IIActive
Exactech 170-36-03
FDA UDI
Class IIActive
Equinoxe 301-15-14
FDA UDI
Class IIActive
Acumatch A Series 132-22-10
FDA UDI
Class IIActive
Equinoxe 341-41-05
FDA UDI
Class IActive
Epic Cannulated Screw System A
FDA UDI
Class IIActive
Equinoxe SPI-008845
FDA UDI
Class IIActive
AcuMatch 140-32-27
FDA UDI
Class IIActive
Vantage 350-22-61
FDA UDI
Class IIActive
Aura 107-05-01
FDA UDI
Class IIActive
Novation 160-21-10
FDA UDI
Class IIActive
Equinoxe 301-09-44
FDA UDI
Class IIActive
Truliant, Activit-E 02-024-47-4014
FDA UDI
Class IIActive
Exactech SK-013517
FDA UDI
Class IIActive
Truliant SPI-024286
FDA UDI
Class IIActive
Truliant, Activit-E 02-023-02-0032
FDA UDI
Class IIActive
Alteon 01-030-42-0640
FDA UDI
Class IIActive
Optetrak Logic 02-013-50-5014
FDA UDI
Class IActive
Equinoxe 340-65-53
FDA UDI
Class IIActive
Alteon 190-21-03
FDA UDI
Class IIActive
Truliant 02-022-47-0014
FDA UDI
Class IIActive
Exactech SC45-40
FDA UDI
Class IIActive
AcuMatch 141-22-07
FDA UDI
Class IActive
AcuMatch 115-24-40
FDA UDI
Class IActive
Alteon 191-13-12
FDA UDI
Class IIActive
Truliant 02-022-47-4515
FDA UDI
Class IIActive
Optetrak Logic 02-013-51-6011
FDA UDI
Class IActive
Optetrak 208-10-20
FDA UDI
Class IIActive
Truliant, Activit-E 02-023-02-0041
FDA UDI
Class IIActive
Equinoxe 315-29-12
FDA UDI
Class IIActive
AcuMatch 135-28-09
FDA UDI
Class IActive
Alteon 01-030-95-0000
FDA UDI
Class IActive
Equinoxe 315-60-01
FDA UDI
Class IIActive
Truliant 02-022-49-0009
FDA UDI
Class IIActive
Vantage 03-PMR-10-0004
FDA UDI
Class IIActive
Vantage 350-22-42
FDA UDI
Class IIActive
Truliant, Activit-E 02-024-51-3014
FDA UDI
Class IIActive
Truliant 02-022-48-5013
FDA UDI
Class IIActive
Optetrak 204-48-04
FDA UDI
Class IIActive
Equinoxe 314-02-03
FDA UDI
Class IIActive
Optetrak Logic 02-012-35-5009
FDA UDI
Class IIActive
Vantage 351-90-04
FDA UDI
Class IActive
Optetrak Logic 02-012-51-1013
FDA UDI
Class IIActive
Optetrak Logic 02-012-45-2030
FDA UDI
Class IIActive
Truliant 02-029-25-3740
FDA UDI
Class IActive
Vantage SPI-038414
FDA UDI
Class IIActive
Novation 142-32-63
FDA UDI
Class IIActive
Truliant® 02-022-57-0010
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Feb 3, 2026Z-1510-2026—open, classified

Impactor handle may be missing cross-pin

Feb 3, 2026Z-1509-2026—open, classified

Impactor handle may be missing cross-pin

Sep 5, 2025Z-0536-2026—open, classified

Due to products that have not completed design updates and performance testing being released/distributed. Products may not conform to design and performance criteria.

Sep 5, 2025Z-0537-2026—open, classified

Due to products that have not completed design updates and performance testing being released/distributed. Products may not conform to design and performance criteria.

Sep 5, 2025Z-0535-2026—open, classified

Due to products that have not completed design updates and performance testing being released/distributed. Products may not conform to design and performance criteria.

Aug 15, 2025Z-2561-2025—open, classified

Reverse Shoulder humeral liners have an articular surface position outside of the dimensional specification within the labeling.

Aug 15, 2025Z-2562-2025—open, classified

Reverse Shoulder humeral liners have an articular surface position outside of the dimensional specification within the labeling.

Dec 31, 2024Z-1166-2025—open, classified

Due to the lack of the Ethylene Vinyl Alcohol (EVOH) barrier layer.

Dec 31, 2024Z-1167-2025—open, classified

Due to the lack of the Ethylene Vinyl Alcohol (EVOH) barrier layer.

Dec 31, 2024Z-1165-2025—open, classified

Due to the lack of the Ethylene Vinyl Alcohol (EVOH) barrier layer.

Apr 26, 2024Z-2236-2024—open, classified

The AcuMatch L-Series 22mm Inner Diameter Bipolar Hip Liner lots were packaged without the specified ethylene vinyl alcohol (EVOH) layer. Between 2004 and August 2021, our packaging process utilized two different types of packaging materials: 1) Low Density Polyethylene (LDPE), Nylon, and EVOH, or 2) LDPE and Nylon without EVOH.

Apr 18, 2024Z-2156-2024—open, classified

Exactech is recalling all affected UHMWPE (ultra-high molecular weight polyethylene) knee patella components packaged in out of specification vacuum bags.

Apr 18, 2024Z-2158-2024—open, classified

Exactech is recalling all affected UHMWPE (ultra-high molecular weight polyethylene) knee patella components packaged in out of specification vacuum bags.

Apr 18, 2024Z-2155-2024—open, classified

Exactech is recalling all affected UHMWPE (ultra-high molecular weight polyethylene) knee patella components packaged in out of specification vacuum bags.

Apr 18, 2024Z-2157-2024—open, classified

Exactech is recalling all affected UHMWPE (ultra-high molecular weight polyethylene) knee patella components packaged in out of specification vacuum bags.

Mar 6, 2024Z-1420-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1423-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1414-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1422-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1406-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1409-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1415-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1405-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1416-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1403-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1407-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1411-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1410-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1425-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1412-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1417-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1424-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1404-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1402-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1408-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1421-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1413-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1418-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1419-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Nov 21, 2023Z-0582-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0587-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0588-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0586-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0584-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0581-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0580-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0583-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0585-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0579-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0578-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0577-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Jun 5, 2023Z-2051-2023—open, classified

The ball and spring housed within the locking mechanism of the handle can dislodge during disassembly or during impaction.

Jun 5, 2023Z-2050-2023—open, classified

The ball and spring housed within the locking mechanism of the handle can dislodge during disassembly or during impaction.

Aug 11, 2022Z-1726-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1733-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1725-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1729-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1730-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1734-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1728-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1727-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1732-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1731-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 30, 2021Z-0027-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0022-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0021-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0026-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0020-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0019-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0024-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0025-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0023-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Jun 29, 2021Z-2131-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2127-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2113-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2126-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2118-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2112-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2130-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2120-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2119-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2133-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2123-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2121-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2114-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2132-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2124-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2129-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2122-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2115-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2116-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2250-2021—completed

Biolox Delta Femoral Head was packaged and labeled as 170-36-00 (36mm +0), but the device was marked as 170-36-03 (36mm +3.5).

Jun 29, 2021Z-2128-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2117-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2125-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2251-2021—completed

Biolox Delta Femoral Head was packaged and labeled as 170-36-00 (36mm +0), but the device was marked as 170-36-03 (36mm +3.5).

May 11, 2021Z-1977-2021—completed

The HAT trial contains a retaining ring that has shown the potential to disengage during use.

Nov 9, 2020Z-0884-2021—open, classified

Potential for incorrect Instructions For Use (IFU) included with an Equinoxe Humeral Stem, Primary, Press Fit, 11mm package.

Oct 6, 2020Z-0459-2021—terminated

The product may be mislabeled.

Oct 6, 2020Z-0460-2021—terminated

The product may be mislabeled.